✦ LIBER ✦

Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry

✍ Scribed by Puymirat, E.; Cohen, S.; Védrenne, G.; Caruba, T.; Sabatier, B.; Danchin, N.; Durand, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Bivalirudin Versus Bivalir

✍ Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Efficacy and safety of argatroban with o

✍ Ignacio Cruz-Gonzalez; Maria Sanchez-Ledesma; Suzanne J. Baron; Josephine L. Hea 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 138 KB

Safety and Efficacy of Bivalirudin With

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

827-6 Underuse of glycoprotein IIb/IIIa

✍ Anselm K Gitt; Uwe Zeymer; Martin G Gottwik; Jean-Pierre Bassand; Keith Dawkins; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB

THE EFFICACY AND SAFETY OF TICAGRELOR AS

✍ Bansilal, Sameer; Wiviott, Stephen; Becker, Richard; Harrington, Robert; Himmelm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 249 KB

The Efficacy and Safety of Prasugrel Wit

✍ Michelle O'Donoghue; Elliott M. Antman; Eugene Braunwald; Sabina A. Murphy; P. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 480 KB